Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Take It From the TOPS Study

Dec 1, 2022/Feature

Medicare data shows that physical therapy of needed intensity improves functionality and saves money across post-acute care settings.

PTJ Author Interview With Shawn Farrokhi: Intervention Type Influences One-Year Escalation-of-Care for Low Back Pain

Jan 4, 2024/Podcast

Active interventions are associated with less specialty care.

Top APTA Podcasts of 2021

Dec 29, 2021/Roundup

APTA podcasts make for compelling listening, whether it's about maximizing your potential or sharing a patient's story of transformation.

Guidelines for Family-Centered Care in the Neonatal, Pediatric, and Adult ICU

Jan 1, 2017/CPG

Guidelines and evidence-based strategies to optimize the support of the family of critically ill patients in the ICU.

Idiopathic Pulmonary Fibrosis in Adults: Diagnosis and Management [NICE CG163] [Updated]

May 23, 2017/CPG

Guideline covers diagnosing and managing idiopathic pulmonary fibrosis in people aged 18 and over.

Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management [NG115]

Jul 26, 2019/CPG

This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (including emphysema and chronic bronchitis) in people aged 16 and older.

Code Pairing Edits: Four Things To Know

Jan 25, 2021/Article

APTA successfully advocated for CMS to lift misguided coding edits, and we're working to bring commercial payers around.

The Therapeutic Alliance

Nov 20, 2018/Perspective

It must be one alliance between the patient, PT, and PTA. 

A Shared Experience: Members Discuss Their Professional Experience in Advocacy

Jul 15, 2022/Podcast

A current APTA student president talks about advocacy to a past student president running for a seat in the Missouri State House of Representatives.

Multiple Sclerosis in Adults: Management [NICE NG220]

Jun 22, 2022/CPG

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over and aims to improve the quality of life for adults with multiple sclerosis. [Formerly NICE CG186.]